Oncogenesis in ovarian cancer

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Tumorigenesis is a multistep process driven by genetic alterations.
• Ovarian cancer's genetic landscape, particularly during initiation and progression, remains less understood compared to other cancers.
• Cytogenetic analyses reveal frequent chromosomal abnormalities in ovarian tumors, increasing with disease progression.

Purpose of the Study:

• To investigate the genetic events contributing to ovarian cancer initiation, progression, and metastasis.
• To identify specific oncogene activations and tumor suppressor gene alterations in ovarian carcinoma.
• To explore the role of inherited mutations in familial breast and ovarian cancer syndromes.

Main Methods:

• Comparative genomic hybridization (CGH) and cytogenetic analysis to detect chromosomal aberrations.
• Analysis of oncogene (K-ras, c-myc, c-erbB-2) and tumor suppressor gene (p53, 11p, 17p, 17q, 6q, 8q) alterations.
• Germline mutation analysis for inherited predisposition in familial cancer cases.

Main Results:

• Increased structural and numerical chromosome changes correlate with ovarian tumor progression.
• Activation of K-ras, c-myc, and c-erbB-2 oncogenes is more frequent in aggressive tumors, linked to poor survival.
• Allelic loss at 11p, 17p, 17q, and 6q suggests involvement of tumor suppressor genes; 6q loss appears specific to ovarian cancer.
• A germline mutation in the p53 tumor suppressor gene was identified in a family with hereditary breast and ovarian cancer.

Conclusions:

• Ovarian cancer etiology involves both acquired somatic mutations in oncogenes and tumor suppressor genes.
• Both somatic and germline alterations contribute to ovarian cancer development.
• Identifying specific genetic alterations aids in understanding ovarian cancer progression and potential therapeutic targets.